Zoetis Inc.
Zoetis
ZTS · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $9.5B
- Assets
- $15.5B
- SEC filing
- DEF 14A
- Filed
- April 8, 2026
Executive Compensation
Compensation reported for Zoetis’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Kristin C. Peck
Chief Executive Officer
$19M
Reported total
- Salary
- $1,350,000
- Stock awards
- $10,218,583
- Incentives
- $2,187,000
- Option awards
- $3,406,229
- Other
- $1,884,697
Wetteny Joseph
Executive Vice President (“evp”) And Chief Financial Officer
$5.6M
Reported total
- Salary
- $800,000
- Stock awards
- $2,849,611
- Incentives
- $832,000
- Option awards
- $949,961
- Other
- $164,941
Jamie Brannan
EVP and Chief Commercial Officer
$4M
Reported total
- Salary
- $720,000
- Stock awards
- $1,673,899
- Incentives
- $673,920
- Option awards
- $557,994
- Other
- $348,528
Robert J. Polzer
Former Evp And President Of Research And Development
$3.7M
Reported total
- Salary
- $710,000
- Stock awards
- $1,666,255
- Incentives
- $590,720
- Option awards
- $555,461
- Other
- $144,721
Roxanne Lagano
Evp, General Counsel And Corporate Secretary
$2.8M
Reported total
- Salary
- $700,000
- Stock awards
- $1,042,198
- Incentives
- $604,800
- Option awards
- $347,495
- Other
- $130,787
Kristin C. Peck
Chief Executive Officer
$19M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed April 8, 2026.
- Salary
- $1.4M
- Stock Awards
- $10.2M
- Option Awards
- $3.4M
- Incentives
- $2.2M
- Other
- $1.9M
Historical Compensation
Kristin C. Peck total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,350,000 | $10,218,583 | $19,046,509 |
| 2024 | $1,300,000 | $9,562,347 | $17,206,760 |
| 2023 | $1,200,000 | $8,774,860 | $15,237,853 |
Named Executive Officers
Kristin C. Peck
Chief Executive Officer
Zoetis · ZTS
$19M
FY 2025 · DEF 14A
Wetteny Joseph
Executive Vice President (“evp”) And Chief Financial Officer
Zoetis · ZTS
$5.6M
FY 2025 · DEF 14A
Jamie Brannan
EVP and Chief Commercial Officer
Zoetis · ZTS
$4M
FY 2025 · DEF 14A
Robert J. Polzer
Former Evp And President Of Research And Development
Zoetis · ZTS
$3.7M
FY 2025 · DEF 14A
Roxanne Lagano
Evp, General Counsel And Corporate Secretary
Zoetis · ZTS
$2.8M
FY 2025 · DEF 14A
Source information
- Company
- Zoetis Inc.
- Ticker
- ZTS · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- April 8, 2026
- SEC accession number
- 0001555280-26-000015
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company